Nanoparticle for SARS-CoV-2 vaccine research, illustration. This synthetic virus-like particle was designed to exploit the structure of the SARS-CoV-2 spike glycoprotein receptor-binding domain to develop a COVID vaccine. | |
Lizenzart: | Lizenzpflichtig |
Credit: | Science Photo Library / Laguna Design |
Bildgröße: | 4150 px × 4150 px |
Modell-Rechte: | nicht erforderlich |
Eigentums-Rechte: | nicht erforderlich |
Restrictions: | - |